TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

Similar documents
TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

Fort Detrick, Maryland

Detection of Prostate Cancer Progression by Serum DNA Integrity

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

Award Number: W81XWH

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

Approved for public release; distribution unlimited

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: A PSCA Promoter Based Avian Retroviral Transgene Model of Normal and Malignant Prostate

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

Expression and Promoter Methylation of P16INK4A During Estrogen-Induced Mammary Carcinogenesis in the ACI Rat. Omaha, NE

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

Approved for Public Release; Distribution Unlimited

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

Award Number: W81XWH

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

TITLE: "Impact of Obesity on Tamoxifen Chemoprevention in a Model of Ductal Carcinoma in Situ"

TITLE: The Role of HOX Proteins in Androgen-Independent Prostate Cancer

La Jolla, CA Approved for Public Release; Distribution Unlimited

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Investigating the Role of TBX2 in the Inhibition of Senescence in Prostate Cancer

TITLE: TREATMENT OF ENDOCRINE-RESISTANT BREAST CANCER WITH A SMALL MOLECULE C-MYC INHIBITOR

Approved for public release; distribution unlimited

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

TITLE: A Tissue Engineering Approach to Study the Progression of Breast Tumor Metastasis in Bone

TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

TITLE: Prostate Expression Databases: Gene Expression Resources for Comparative Studies of Prostate Carcinogenesis

Award Number: W81XWH TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer

Award Number: W81XWH TITLE: A Novel Membrane-Permeable, Breast-Targeting, Pro-Apoptotic Peptide for Treatment of Breast Cancer

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

TITLE: Interchromosomal Associations that Alter NF1 Gene Expression Can Modify Clinical Manifestations of Neurofibromatosis 1. Palo Alto, CA 94304

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

Award Number: W81XWH TITLE: Regenerative Stem Cell Therapy for Breast Cancer Bone Metastasis

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: University of Illinois Chicago, IL

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

CONTRACTING ORGANIZATION: Vanderbilt University Medical Center Nashville, TN

Award Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer

TITLE: HER2/neu Antisense Therapeutics in Human Breast Cancer. CONTRACTING ORGANIZATION: Washington University School of Medicine St.

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

CONTRACTING ORGANIZATION: University of Texas M.D. Anderson Cancer Center Houston, TX 77030

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

TITLE: The Importance of Autophagy in Breast Cancer Development and Treatment

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029

TITLE: Breast Tumor-Generated Type 1 Collagen Breakdown Fragments Act as Matrikines to Drive Osteolysis

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Effect of COX-2 (PGE2) and IL-6 on Prostate Cancer Bone Mets

TITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

Transcription:

AD AWARD NUMBER: DAMD17-02-1-0662 TITLE: Dietary Genistein and Prostate Cancer Chemoprevention PRINCIPAL INVESTIGATOR: Coral A. Lamartiniere, Ph.D. CONTRACTING ORGANIZATION: The University of Alabama at Birmingham Birmingham, Alabama 35292-0111 REPORT DATE: April 2006 TYPE OF REPORT: Final Addendum PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for Public Release; Distribution Unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE (DD-MM-YYYY) 2. REPORT TYPE April 2006 Final Addendum 3. DATES COVERED (From - To) 1 Apr 05 31 Mar 06 4. TITLE AND SUBTITLE 5a. CONTRACT NUMBER Dietary Genistein and Prostate Cancer Chemoprevention 5b. GRANT NUMBER DAMD17-02-1-0662 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d. PROJECT NUMBER Coral A. Lamartiniere, Ph.D. E-Mail: Coral@uab.edu 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER The University of Alabama at Birmingham Birmingham, Alabama 35292-0111 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for Public Release; Distribution Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT The goal of our research was to determine if there is a developmental window for suppressing prostate cancer with the phytoestrogen, genistein, and its mechanism (s) of chemoprevention. Life-time (starting at birth) exposure to genistein was more effective in suppressing chemically-induced prostate cancer in rats than neonatallprepubertal or adult only exposures to genistein. Neonatallprepubertal genistein exposure did not alter prostate bud development. Dietary genistein during the neonatallprepubertal period as well as during adulthood resulted in decreased androgen receptor, but not estrogen receptors alpha and beta, in dorsolateral prostates of 70 day old rats, suggesting that early exposure to genistein can have a programming effect on androgen receptor expression. However, genistein at each period of postnatal development did not alter androgen receptor mrna in the prostate, data that argues against genistein causing gene silencing via DNA methylation mechanism in the prostate of rats. On the other hand, genistein in the diet resulted in increased apoptosis in the prostate. Phospho-Akt and Bcl-2 protein levels were decreased and Bax was increased in prostates of rats fed genistein in tlle diet, protein regulation consistent with increased apoptosis, a cellular mechanism that can suppress prostate cancer development. 15. SUBJECT TERMS Genistein, Rat, Prostate, Cancer Chemoprevention 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT a. REPORT U b. ABSTRACT U 18. NUMBER OF PAGES c. THIS PAGE U UU 11 19a. NAME OF RESPONSIBLE PERSON USAMRMC 19b. TELEPHONE NUMBER (include area code) Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std. Z39.18

dorsolateral prostates of 70 day old rats, suggesting that early exposure to genistein can have a programming or imprinting effect on androgen receptor expression. However, genistein at each period of postnatal development did not alter androgen receptor mrna in the prostate, data that argues against genistein causing gene silencing via DNA methylation mechanism in the prostate of rats. On the other hand, genistein in the diet resulted in increased apoptosis in the prostate. Phospho-Akt and Bcl-2 protein levels were decreased and Bax was increased in prostates of rats fed genistein in the diet, protein regulation consistent wit11 increased apoptosis, a cellular mechanism that can suppress prostate cancer development. None References Appendices List of personnel receiving pay from the research effort 10